hVIVO PLC
LSE:HVO

Watchlist Manager
hVIVO PLC Logo
hVIVO PLC
LSE:HVO
Watchlist
Price: 19.5 GBX -1.02%
Market Cap: 132.7m GBX
Have any thoughts about
hVIVO PLC?
Write Note

hVIVO PLC
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

hVIVO PLC
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
hVIVO PLC
LSE:HVO
Common Stock
ÂŁ680k
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
22%
Oxford Nanopore Technologies PLC
LSE:ONT
Common Stock
ÂŁ86k
CAGR 3-Years
34%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Common Stock
ÂŁ169k
CAGR 3-Years
0%
CAGR 5-Years
281%
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Common Stock
ÂŁ1.8m
CAGR 3-Years
25%
CAGR 5-Years
29%
CAGR 10-Years
28%
Ergomed PLC
LSE:ERGO
Common Stock
ÂŁ508k
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Common Stock
ÂŁ4.5m
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

hVIVO PLC
Glance View

Market Cap
132.7m GBX
Industry
Life Sciences Tools & Services

hVIVO PLC provides pharmaceutical development services. The firm is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The company provides end-to-end early clinical development services to its client base, which includes global biopharma companies. The company offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The company offers additional clinical field trial services, such as patient recruitment and clinical trial site services. The company runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.

HVO Intrinsic Value
26.37 GBX
Undervaluation 26%
Intrinsic Value
Price

See Also

What is hVIVO PLC's Common Stock?
Common Stock
680k GBP

Based on the financial report for Jun 30, 2024, hVIVO PLC's Common Stock amounts to 680k GBP.

What is hVIVO PLC's Common Stock growth rate?
Common Stock CAGR 10Y
22%

Over the last year, the Common Stock growth was 0%.

Back to Top